Cross-Reference to Related Application

[0001] The present application claims the benefit of U.S. Patent Application No. 14/793,357 filed July 7, 2015, which is incorporated herein by reference in its entirety.

Field of the Disclosure

[0002] The present subject matter relates to monitoring the medication intake of a subject. More particularly, the present subject matter relates to monitoring the medication intake of a subject using a medication container incorporating an electrical circuit with radio frequency identification ("RFID") technology.

Description of Related Art

[0003] Frequently, a doctor or medical care provider will issue instructions to a subject to periodically ingest one or more doses of medication in the form of a pill or tablet or capsule or the like as part of a treatment regimen. Unless the subject is within a facility under the control of the doctor or medical care provider (e.g., a hospital or nursing home), it can be difficult for the doctor or medical care provider to know whether the subject is ingesting the prescribed medication at the proper times. Accordingly, it would be advantageous to provide systems and methods that allow a doctor or medical care provider to monitor the medication compliance of a subject. Summary

[0004] There are several aspects of the present subject matter, which may be embodied separately or together in the devices and systems described and claimed below. These aspects may be employed alone or in combination with other aspects of the subject matter described herein, and the description of these aspects together is not intended to preclude the use of these aspects separately or the claiming of such aspects separately or in different combinations as may be set forth in the claims appended hereto.

[0005] In one aspect, a medication container is provided with at least one medication- containing cell, with a cover overlaying the cell. The medication contained within the cell is accessed through the cover. The medication container also includes an electrical circuit having a radio frequency identification (" FID") chip associated with the cover and electrically coupled to an antenna. The antenna is configured to communicate with an RFID reader to detect whether the cell has been accessed through the cover.

Brief Description of the Drawings

[0006] Fig. 1 is a top plan view of a medication container according to an aspect of the present disclosure;

[0007] Fig. 2 is a top plan view of another embodiment of a medication container according to an aspect of the present disclosure; and

[0008] Fig. 3 is a diagrammatic view of yet another embodiment of a medication container according to an aspect of the present disclosure. Description of the Illustrated Embodiments

[0009] As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriate manner.

[0010] According to an aspect of the present disclosure, a doctor or medical care provider may remotely monitor medication compliance through the use of a system that combines an FID- enabled medication container, generally designated at 10 (Fig. 1) and an RFID reader (not illustrated). An electrical circuit, generally designated at 12, is incorporated into the medication container 10 and configured to allow for the status of a medication-containing cell 14 of the medication container 10 to be monitored to determine whether the cell 14 has been accessed by a subject, in accordance with a prescribed medication routine. Figs. 2 and 3 illustrate two alternative embodiments of such a system.

[0011] In the embodiment of Fig. 1, the medication container 10 includes at least one cell 14 in which a medication is contained. Preferably, the medication container 10 includes a plurality of identical cells 14 (as in the illustrated embodiment), but it is also within the scope of the present disclosure for a medication container to include only one cell or a plurality of cells differently configured with respect to volume, depth, perimeter size, perimeter shape, color, texture, for example, and combinations thereof.

[0012] Each cell 14 may be formed of any suitable material but, in one embodiment, each cell is formed of a plastic material or another material that is substantially non-conductive. It may be advantageous for the cells 14 to be formed of a material that is generally rigid, but sufficiently deformable that a human may deform the individual cells using a finger or digital force and manipulation. In a preferred embodiment, the body of the medical container 10 takes the general form of a blister pack, with a thin plastic sheet being provided with a plurality of chambers that had been formed for containing one medication or multiple medications, such as medications to be accessed and administered at substantially the same time. Each chamber or chambers can be formed as desired. For example, the chamber or chambers can be vacuum-formed depressions or formations that each defines a cell 14 for receiving a dose of medication.

[0013] In some instances, it may be thought to be advantageous or efficient for a medication container having a plurality of chambers or cells to be provided from a single sheet that is formed to define all of the chambers or cells It is also within the scope of the present disclosure for the chambers or cells of a single medication container to be separately or non-integrally formed such that less than all of a plurality of the chambers or cells are formed from a formable sheet. This can result in formation of multiple groups or modules having a plurality of chambers or cells grouped in a row or otherwise in general alignment with each other. Each group or module can then assembled into a container of desired size and configuration. Other embodiments may have individual cells formed as separate modules. Chamber or cell formation materials typically comprise polymeric sheeting or cellulosic sheeting or combinations of sheeting materials are selected that can be formed efficiently while providing adequate protection to the contents of each chamber or cell.

[0014] Whatever material or configuration is utilized, each chamber or cell 14 is closed or overlaid by a cover 16 through which medication within the cell 14 may be accessed. In one embodiment, the cover 16 is a thin sheet of material, such as a metallic foil, which may be broken to allow a medication to pass out of the chamber or cell 14. In such an embodiment, a base of the cell 14 may be pressed toward the frangible cover 16 by a user until the force on the cover 16 exceeds the strength of the cover 16, at which point the cover 16 breaks and the medication may be removed from the cell 14. Alternatively, the chamber or cell 14 may remain untouched, while the cover 16 is directly engaged and broken by digital force or with simple tool assist in order to remove medication from the cell 14. If the medication container 10 is provided with a plurality of cells 14, it may be preferred for a single cover 16 to overlay all of the cells 14 (as in the illustrated embodiment), but it is also within the scope of the present disclosure for two or more cells of the same medication container to be provided with a common cover, while two or more other cells are provided with a different or separate covers. In another embodiment, different cells are each overlaid by a separate, non-frangible (e.g., hinged) cover.

[0015] The electrical circuit 12 incorporated into the medication container 10 includes an RFID chip 18 associated with a chamber or cell 14 and electrically coupled to an antenna 20. The RFID chip 18 may be variously configured without departing from the scope of the present disclosure. For example, in one embodiment, the RFID chip 18 may be of the form defined in the EPC Classl Gen2 or other protocols that require a bi-directional communication or of the form typically described as "tag talks first", where the RFID chip 18 emits a data burst containing a unique identify at pseudo random intervals when powered. If the medication container 10 includes a plurality of cells 14 (eight in the embodiment of Fig. 1), then it may be advantageous for the circuit 12 to include a plurality of RFID chips 18 (preferably at least as many as the number of chambers or cells 14), with a different RFID chip 18 associated with each one of the cells 14. If a plurality of RFID chips 18 are provided, then they may all be electrically coupled to the antenna 20 in the same way (as shown in Fig. 1). Alternatively, two RFID chips 18 of the same electrical circuit 12 may be electrically coupled to the same antenna 20 in different ways (e.g., with one being electrically coupled to the antenna 20 as in the embodiment of Fig. 1 and another being electrically coupled to the antenna 20 as in the embodiment of Fig. 2, which is described below).

[0016] In the illustrated embodiment, each RFID chip 18 is associated with a common antenna 20 by a frangible conductor or link 22. In one embodiment, the frangible conductor or link 22 may be printed onto the cover 16 or otherwise integrated into the cover 16, but it also within the scope of the present disclosure for the frangible conductor or link 22 to be provided separately from the cover 16. The frangible conductor or link 22 is at least partially positioned over the cell 14 associated with the RFID chip 18, such that accessing the medication in the cell 14 (e.g., by breaking or opening the cover 16) breaks the frangible conductor or link 22, thereby uncoupling the associated RFID chip 18 from the antenna 20. For example, the medication may be sealed within the chamber or cell 14, and access can be gained by breaking the cover or otherwise compromising the integrity of the chamber or cell. As will be described in greater detail, the antenna 20 cooperates with an RFID reader to detect when a particular RFID chip 18 is no longer electrically coupled to the antenna 20 (i.e., when the chamber or cell 14 associated with that RFID chip 18 has been accessed).

[0017] If the medication container 10 includes a plurality of chambers or cells 14 and RFID chips 18, it may be advantageous for each RFID chip 18 to be programmed with a unique identity, such that when the system determines that an RFID chip 18 has been uncoupled from the antenna 20, it is possible to determine exactly which of the RFID chips 18 has been uncoupled from the antenna 20. Such unique identities may be associated with a particular cell 14 either at the point of use or during manufacture using a map of the position/identity structure.

[0018] The antenna 20 may be configured to communicate with an RFID reader at a variety of frequencies, such as high frequency (for detection of the electrical circuit 12 at a relatively short range) or ultra-high frequency (for detection of the electrical circuit 12 at a longer range). In one embodiment, an RFID chip 18 of the electrical circuit 12 is configured to periodically or randomly transmit a signal to the antenna 20 (e.g., a signal indicative of the identity of the RFID chip 18), with the antenna 20 transmitting a signal to the RFID reader to indicate that the frangible link 22 associated with the RFID chip 18 remains intact (i.e., that the chamber or cell 14 associated with the RFID chip 18 has not yet been accessed through or by opening of the cover 16). Alternatively, the RFID reader may be programmed to transmit signals to the antenna 20, at which time the connection between the RFID chip 18 and the antenna 20 is interrogated or checked. If the interrogation reveals that the RFID chip 18 remains electrically coupled to the antenna 20, then the antenna 20 may transmit a signal to the RFID reader that the cell 14 associated with the RFID chip 18 has not yet been accessed through the cover 16. On the other hand, if interrogation reveals that the RFID chip 18 is no longer electrically coupled to the antenna 20, then the antenna 20 may transmit a signal to the RFID reader that the cell 14 associated with the RFID chip 18 has been accessed through the cover 16.

[0019] The RFID reader (or a separate electronic device associated or associable with the RFID reader) may include a real-time clock, thereby allowing the system to determine the time (or at least the approximate time) at which the cell 14 associated with a particular RFID chip 18 was accessed through the cover 16. With this information, the system may determine whether a subject is following a prescribed medication routine (i.e., ingesting the proper medication at the proper time) or not (e.g., ingesting an improper medication at a particular time or failing to ingest the proper medication at the prescribed time). In another embodiment (which is described in greater detail herein), the electrical circuit of the medication container may include a real-time clock, thereby allowing a component of the electrical circuit to record the time at which a frangible link 22 was broken (i.e., the time at which a cell 14 associated with the frangible link 22 was accessed through the cover 16). This gets away from the basic concept as written, the real time clock device would also have to include the ability to determine which chip is connected or not, determine a change of that state, and write that data to a permanently connected RFID device such as the master RFID chip to act as the communication medium. This a fully active circuit, and the real time clock device may as well just monitor the cell connections, determine the connection state, and emulate an RFID tag to send it to the host - which is what CC have built.

[0020] The electrical circuit 12 may include additional components without departing from the scope of the present disclosure. For example, in one embodiment, the electrical circuit 12 includes a motion detector and a power source electrically coupled to the RFID chip(s) 18 and antenna 20. Prior to detecting motion, the electrical circuit 12 may operate in a relatively low power state. Upon the motion detector detecting motion (e.g., when a subject has picked up or moved the medication container 10 to access medication in one of the chambers or cells 14), the electrical circuit 12 may move from the relatively low power state to a relatively high power state, in which the antenna 20 may transmit signals to an RFID reader, and alternatively when power is used to increase the operating range of the RFID tags in a way commonly referred to in the art as "Battery Assisted Passive," the status of the RFID chips can be read at either longer range or with a lower power reader device.

[0021] In an alternative embodiment, the RFID chips may be inhibited from communication with a reader system when in low power state and enabled in the high power state. This is useful as it ensures that only RFID devices associated with a moving blister pack are active, reducing the number of parts attempting to communicate with the reader, when a relatively large number of blister packs are present. At any suitable time (e.g., after a certain amount of time during which the motion detector fails to detect motion), the electrical circuit 12 may move back into the relatively low power state from the relatively high power state. The configuration of the motion detector and power source may vary without departing from the scope of the present disclosure. For example, in one embodiment, the motion detector may be provided as a passive infrared device, which operates based on the presumption that medication will only be removed from a cell 14 when a human is present.

[0022] In another embodiment, the electrical circuit 12 may be provided with a second antenna, which allows the electrical circuit 12 to be interrogated at a second or alternative frequency. The second antenna may take any suitable form (e.g., a coil for receiving magnetic field signals or capacitive pads for receiving electric field signals) and be variously associated with the medication container 10 without departing from the scope of the present disclosure.

[0023] The RFID reader of the system also may be provided with any of a variety of components and functionality without departing from the scope of the present disclosure. For example, the RFID reader may have its own wide area communication capability, such as via WiFi, 3G, or 4G, or may communicate via another linking system, such as Bluetooth, to a smart device such as a mobile phone or tablet or the like.

[0024] As described above, in the embodiment of Fig. 1, an RFID chip 18 is configured to be uncoupled from the antenna 20 upon the associated chamber or cell 14 being accessed through the cover 16. An alternative embodiment of a medication container, generally designated as 10a, is illustrated in Fig. 2. In this embodiment, the RFID chip 18 remains electrically coupled to the antenna 20 after the associated cell 14 has been accessed through the cover 16. In this embodiment, each RFID chip 18 is provided with an associated anti-tamper chip 24 (e.g., a G2iL+ device from NXP Semiconductors of Eindhoven, The Netherlands). When the cell 14 associated with the anti-tamper chip 24 is accessed (e.g., by breaking the cover 16 overlaying the cell 14), the state of the anti-tamper chip 24 changes, which changes a bit in memory, which is indicative of the cell 14 having been accessed through the cover 16. This change will affect the signal received by the antenna 20 from the RFID chip 18 associated with the anti-tamper chip 24, which affects the signal that the antenna 20 transmits to an RFID reader of the system. The RFID reader (or another component of the system) may be configured or programmed to recognize that the different signal from the antenna 20 indicates that one of the cells 14 has been accessed, typically being through the cover 16.

[0025] Another difference between the embodiment illustrated in Fig. 1 and that illustrated in Fig. 2 is the way in which the respective RFID chips 18 are incorporated into the respective medication container 10, 10a. In the embodiment of Fig. 1, a greater amount of foil is illustrated than in Fig. 2. In Fig. 1, the substantially complete layer of foil may comprise at least a portion of the cover 16 (along with a support layer formed of paper or the like, optionally), with laser-formed gaps being defined at selected locations of the foil. Each RFID chip 18 is installed across the gap in the foil by a "flip chip" method or the like to associate the RFID chips 18 with the medication container 10. In contrast, the RFID chips 18 of the embodiment of Fig. 2 are incorporated into the associated medication container 10a according to a suitable alternative approach. It should be understood, however, that the RFID chip-connection approach of Fig. 1 may be used to connect the RFID chips 18 of Fig. 2, as well as for the RFID chips 18 of Fig. 1 to be connected by an approach other than a "flip chip" method.

[0026] Fig. 3 illustrates another embodiment of a medication container, generally designated at 10b, according to the present disclosure. The medication container 10b of Fig. 3 may be provided according to the above description of either embodiment of Figs. 1 and 2 (indicated generally at 10, 10a in Fig. 3), but with additional components incorporated into the electrical circuit, generally designated at 12a. The various components illustrated in Fig. 3 and described below may be practiced in any combination or individually without departing from the scope of the present disclosure.

[0027] In the embodiment illustrated in Fig. 3, the electrical circuit 12a is provided with a master RFID chip 26 electrically coupled to the antenna 20. In contrast to the RFID chips 18 of Figs. 1 and 2, the master RFID chip 26 is not associated with any particular chamber or cell 14, but instead with the medication container 10b itself. Also in contrast to the embodiments of Fig. 1, the master RFID chip 26 is configured to remain coupled to the antenna 20 during use, rather than ever becoming uncoupled from the antenna 20. The master RFID chip 26 may be programmed with data indicative of the identity of the medication container 10b, such that an RFID reader (either the same one that monitors the status of the individual cells or a different RFID reader) may track the medication container 10b as part of an inventory management system or the like (typically at ultra-high frequency to track the medication container 10b in a relatively large read field). The master RFID chip 26 may even allow for the medication container 10b to be monitored following use without having to physically contact the medication container 10b, provided that the medication container 10b is not disposed of in a receptacle that interferes with signals to and/or from the antenna 20 (e.g., a metallic disposal container). A reader system may, upon determining which RFID chips are coupled to the common antenna as well as the master chip 26, write to master chip 26 a data set containing the time at which chips were present at that time, The data set may only be written when there is a change of the state of which chips are connected, The data set stored in master chip 26 may be retrieved via a reader at a later time to allow post use analysis, although this is considered of lower value than real time monitoring.

[0028] The electrical circuit 12 of Fig. 3 is further provided with a microcontroller or low power reader/writer device 28, which is electrically coupled to the medication container 10b by any suitable means (e.g., by capacitive contact via two large pads 30 or by an F signal in a near or far field). In a particular embodiment, which is illustrated in Fig. 3, the reliability of the connection between the microcontroller 28 and the medication container 10b is greatly enhanced by having a small number of large connections. The connection may carry a signal at ultra-high frequency or at a lower frequency. For example, the clock of the microcontroller 28 executing a read/write operation; typical frequencies for the connection would be in the range of 4 M Hz to 32 M Hz, although lower or higher frequencies may be used. Some RFID chips 18 of the electrical circuit 12 of the medication container 10b, specifically those without internal coupling capacitors, may be interrogated using data signals at the supply voltage of the microcontroller 28.

[0029] The microcontroller 28 may be programmed to register and record a change in the structure of the electrical circuit 12 (corresponding to one of the cells 14 of the medication container 10b being accessed through the cover 16). If the medication container 10b includes a plurality of chambers or cells 14, the microcontroller 28 may separately monitor the status of each chamber or cell 14 and distinguish them based on the identity of the associated RFID chip 18 and the unique signal transmitted by the associated RFID chip 18. In the illustrated embodiment, a real-time clock 32 is electrically coupled to the microcontroller 28, which allows the microcontroller 28 to register and record the time at which a particular cell 14 of the medication container 10b was accessed through the cover 16. Alternatively, rather than storing this information itself, the microcontroller 28 may be programmed to write the information into a separate storage location (e.g., an RFID chip of the electrical circuit 12). By storing information about the use of the medication container 10b, the microcontroller 28 allows for all of the information to be accessed by an RFID reader with fewer interactions (e.g., a single interaction) between the RFID reader and the electrical circuit 12 of the medication container 10b.

[0030] It will be understood that the embodiments described above are illustrative of some of the applications of the principles of the present subject matter. Numerous modifications may be made by those skilled in the art without departing from the spirit and scope of the claimed subject matter, including those combinations of features that are individually disclosed or claimed herein. For these reasons, the scope hereof is not limited to the above description but is as set forth in the following claims, and it is understood that claims may be directed to the features hereof, including as combinations of features that are individually disclosed or claimed herein.